logo-loader
viewFrontier IP Group PLC

Frontier IP companies tackling coronavirus on numerous fronts

At end 2019, the net asset value of the portfolio was 46.6p, up from 41.4p in June, while cash balances stood at £4mln

Frontier IP Group PLC -
Frontier's companies have direct and indirect involvement in the battle

Frontier IP Group PLC (LON:FIPP) has highlighted how the Intellectual property specialist's portfolio companies are adapting to the coronavirus threat.

Among them, Neil Crabb, Frontier's chief executive, said The Vaccine Group is working on animal vaccines intended to prevent COVID-19 and related coronaviruses from re-emerging, or emerging, from animal populations to infect humans again - the so-called spill-over threat.

Amprologix is developing new classes of antibiotics to help tackle another global threat to human health, antimicrobial resistance.

Molendotech's technology to swiftly detect harmful bacteria in water is already being commercialised by Palintest, a subsidiary of FTSE 100 group Halma.

Less directly, Elute Intelligence is using AI to search and compare complex documents to help find the most relevant research.

Fieldwork Robotics is developing technology to harvest soft fruit and vegetables and can help farmers if labour clampdowns become more acute and affect the ability of seasonal migrant labour to travel.

Neil Crabb added there are problems arising from the virus in that funding rounds might be delayed while universities are shutting down non-coronavirus research.

At end 2019, the net asset value of the portfolio was 46.6p, up from 41.4p in June, while cash balances stood at £4mln.

Quick facts: Frontier IP Group PLC

Price: 74.5 GBX

AIM:FIPP
Market: AIM
Market Cap: £40.98 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Frontier IP Group PLC named herein, including the promotion by the Company of Frontier IP Group PLC in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Frontier IP Group teams up with University of Cambridge to tackle gum disease

Frontier IP Group PLC's (LON:FIPP) Neil Crabb discusses with Proactive London's Andrew Scott a new joint project between themselves and the University of Cambridge to tackle gum disease. The study's received a £52,891 grant from the National Biofilms Innovation Centre (NBIC). The...

on 19/6/20

2 min read